U.K. regulator found total of 30 cases of blood clot events after AstraZeneca vaccine use
British regulators on Thursday said they have identified 30 cases of rare blood clot events after the use of the AstraZeneca COVID-19 vaccine, 25 more than the agency previously reported.
British regulators on Thursday said they have identified 30 cases of rare blood clot events after the use of the AstraZeneca COVID-19 vaccine, 25 more than the agency previously reported. The Medicines and Healthcare products Regulatory Agency said it had received no such reports of clotting events following use of the vaccine made by BioNTech SE and Pfizer Inc..
The health officials said they still believe the benefits of the vaccine in the prevention of COVID-19 far outweigh any possible risk of blood clots.
Some countries are restricting use of the AstraZeneca vaccine while others have resumed inoculations, as investigations into reports of rare, and sometimes severe, blood clots continue.
On March 18, the UK medicines regulator said that there had been five cases of a rare brain blood clot among 11 million administered shots.
On Thursday, it put the count at 22 reports of cerebral venous sinus thrombosis, an extremely rare brain clotting ailment, and eight reports of other clotting events associated with low blood platelets out of a total of 18.1 million doses given.
A source: ctvnews.ca
The Rocket and Artillery formations of the Azerbaijan Army conduct live-fire exercises in accordance with the combat training plan for 2021, the Ministry of Defense of Azerbaijan told Baku Tribune.
.jpg&h=67&w=67&zc=1&q=100)
LAST NEWS
Editor's note: Eugene Chausovsky is a senior analyst at the Newlines Institute. Chausovsky previously served as senior Eurasia analyst at the geopolitical analysis firm Stratfor for more than 10 years. His work focuses on political, economic, and security issues pertaining to Russia, Eurasia, and the Middle East.
